Amalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spread
about
Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.Ablation of nectin4 binding compromises CD46 usage by a hybrid vesicular stomatitis virus/measles virus.Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most EffectiveOncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinity.Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus/measles virus hybrid VSV-FH a growth advantage over measles virus.Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.
P2860
Amalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spread
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Amalgamating oncolytic viruses ...... s, and accelerate their spread
@en
Amalgamating oncolytic viruses ...... , and accelerate their spread.
@nl
type
label
Amalgamating oncolytic viruses ...... s, and accelerate their spread
@en
Amalgamating oncolytic viruses ...... , and accelerate their spread.
@nl
prefLabel
Amalgamating oncolytic viruses ...... s, and accelerate their spread
@en
Amalgamating oncolytic viruses ...... , and accelerate their spread.
@nl
P2093
P2860
P356
P1433
P1476
Amalgamating oncolytic viruses ...... s, and accelerate their spread
@en
P2093
Camilo Ayala-Breton
Emily K Mader
Lukkana Suksanpaisan
P2860
P304
P356
10.1038/MT.2013.164
P577
2013-07-11T00:00:00Z